Found 1 articles for: "Diffuse Photosensitive Bullous Dermatitis"

Successful Outpatient Management of Diffuse Photosensitive Bullous Dermatitis Following Pembrolizumab Therapy

June 2022 | Volume 21 | Issue 6 | Case Reports | 668 | Copyright © June 2022

Immune checkpoint inhibitors including programmed death protein 1 inhibitors show great therapeutic benefit for numerous advanced malignancies but can cause a spectrum of immune-related adverse events...
Read More